Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=astmLatest Financial News for Aastrom Biosciences, Inc.en-usMon, 21 Dec 2009 21:00:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091221/180723.html?.v=1ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , a leading developer of autologous cell products for the treatment of severe, chronic cardiovascular diseases, announced today that shareholders of the Company approved all five proxy proposals at the Annual Meeting of Shareholders held December 14, 2009.yahoo_finance/818968644Mon, 21 Dec 2009 21:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091217/astm8-k.htmlyahoo_finance/3013289161Thu, 17 Dec 2009 19:15:45 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091209/179989.html?.v=1ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , a leading developer of autologous cell products for the treatment of severe, chronic cardiovascular diseases, announced today that the NASDAQ Hearings Panel has granted the Company's request to remain listed on the NASDAQ Stock Market until March 31, 2010, subject to certain conditions.yahoo_finance/4258129008Wed, 9 Dec 2009 19:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091209/cl23632.html?.v=1Aastrom Biosciences announces the following Webcast:yahoo_finance/932552835Wed, 9 Dec 2009 16:51:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091208/2615_id.html?.v=1Geron jumped on Tuesday following positive interim data in leukemia study.yahoo_finance/2028379919Tue, 8 Dec 2009 14:36:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12voocgig/*http%3A//www.thestreet.com/_yahoo/story/10637120/1/geron-stemcells-late-day-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1097052206Wed, 2 Dec 2009 20:04:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091202/2601_id.html?.v=1A major breakthrough for stem cell research sent stocks soaring on Wednesday.yahoo_finance/2262022244Wed, 2 Dec 2009 19:23:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091116/178435.html?.v=1ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , a leading developer of autologous cell products for the treatment of severe, chronic cardiovascular diseases, announced that two oral presentations regarding the Company's vascular clinical program were given Sunday evening at an American Heart Association Satellite Symposium titled "Can We Really Grow New Blood Vessels?" in Orlando, FL:yahoo_finance/61287294Mon, 16 Nov 2009 11:55:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091116/178434.html?.v=1ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , a leading developer of autologous cell products for the treatment of severe, chronic cardiovascular diseases, announced today that Amit N.yahoo_finance/439306739Mon, 16 Nov 2009 11:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=astmyahoo_finance/818156317Fri, 13 Nov 2009 14:05:16 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091113/178338.html?.v=1DALLAS -- InvestorSoup.com announces an investment report featuring Hard To Treat Diseases Inc. . The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.yahoo_finance/1484105775Fri, 13 Nov 2009 11:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091111/2528_id.html?.v=1A successful rodent study showed promise for future treatment of spinal injuries.yahoo_finance/3565340595Wed, 11 Nov 2009 16:28:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091110/178089.html?.v=1ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , a leading developer of autologous cell products for the treatment of chronic cardiovascular diseases, today announced that the Company will initiate its second clinical trial for the treatment of dilated cardiomyopathy , a severe disease associated with chronic heart failure, after a positive 30-day review of Aastrom's Investigational New Drug submission by the U.S.yahoo_finance/2714639053Tue, 10 Nov 2009 18:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/twst/091109/pharma33.html?.v=1yahoo_finance/1383835371Mon, 9 Nov 2009 18:45:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091106/astm8-k.htmlyahoo_finance/1920054790Fri, 6 Nov 2009 18:45:39 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091106/177813.html?.v=1ANN ARBOR, Mich. -- Aastrom Biosciences, Inc. , a leading developer of autologous cell products for the treatment of chronic cardiovascular diseases, today reported financial results and operational updates for the first fiscal quarter ended September 30, 2009.yahoo_finance/815185290Fri, 6 Nov 2009 18:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091030/2486_id.html?.v=1Investors cheered results from Geron on Friday, giving selected stem cell stocks a much needed boost.yahoo_finance/3756197562Fri, 30 Oct 2009 15:47:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091030/177026.html?.v=1LAS VEGAS -- A Murphy Analytics report and profile featuring BrainStorm and detailing its achievements in stem cell research has been released. This report is of potential interest to investors of leading stem cell equities Geron , Osiris Therapeutics , Aastrom Biosciences and StemCells .yahoo_finance/2508847596Fri, 30 Oct 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091027/astm8-k.htmlyahoo_finance/3552000300Tue, 27 Oct 2009 20:05:16 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091020/astm8-k.htmlyahoo_finance/2474706173Tue, 20 Oct 2009 13:06:38 Etc/GMT